Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Cangene Corporation

Below is an extended Cangene Corporation news listing. Click here to return to the Cangene Corporation main Biocorporate entry.

BioNews Results for Cangene Corporation:
Cangene acquires U.S. commercialization rights for HepaGam B from Apotex Pharma Live: Oct 23 2009 5:31AM Matching: cangene
Cangene acquires US commercialization rights for HepaGam B from Apotex PharmaBiz: Oct 22 2009 5:38AM Matching: cangene
Cangene acquires U.S. commercialization rights for HepaGam B from Apotex Bionity.com: Oct 22 2009 8:12AM Matching: cangene
Cangene Corporation announces financial results for the fiscal year ended July 31, 2009 News-Medical.Net: Oct 22 2009 5:48AM Matching: cangene
Bay Street Stocks Finish Strong Thursday - Canadian Commentary RTTNews.com: Oct 22 2009 9:09PM Matching: cangene
Cangene announces highest-ever financial results for fiscal 2009 with net income up 102% to $59.9 million or 86 cents per share Individual.com: Oct 22 2009 1:30AM Matching: cangene
Cangene Corporation (CC:CNJ) Acquires U.S. Commercialization Rights for HepaGam B(R) from Apotex Corp. (JOBS); BioSpace: Oct 21 2009 3:26AM Matching: cangene
Cangene to host fiscal 2009 conference call on Thursday October 22, 2009 at 11:00 a.m. Eastern time Therapeutics Daily: Oct 21 2009 1:41AM Matching: cangene
Cangene to acquire U.S. commercialization rights for HepaGam B News-Medical.Net: Oct 20 2009 8:45AM Matching: cangene
Cangene signs agreement with Apotex Group to acquire U.S. commercialization rights for HepaGam B News-Medical.Net: Oct 20 2009 4:17AM Matching: cangene
Cangene to host fiscal 2009 conference call on Thursday October 22, 2009 at 11:00 a.m. Eastern time Individual.com: Oct 20 2009 7:27PM Matching: cangene
Cangene to host fiscal 2009 conference call on Thursday October 22, 2009 at 11:00 a.m. Eastern time CNW Telbec: Oct 20 2009 9:39PM Matching: cangene
Cangene acquires U.S. commercialization rights for HepaGam B(R) from Apotex CNW Telbec: Oct 19 2009 10:56PM Matching: cangene
Maxygen Announces Consummation of Joint Venture Transaction With Astellas Pharma Live: Sep 21 2009 1:30PM Matching: cangene

«Cangene Corporation

This page contained an extended Cangene Corporation news listing. Click here to return to the Cangene Corporation main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.